Direct to Patient – Working With Your Investigator Sites & Courier to Create a Successful Partnership (WS5)
- Date:
- 1 May 2018
- Time:
- -
- Available Seats:
- 31
The attendee will be able to:
- Describe two (2) benefits each for the clinical site, sponsor and patient of a direct to patient trial.
- Identify at least two (2) risks for sponsors conducting direct to patient trials and develop effective mitigation strategies for these risks.
- List no fewer than 3 study characteristics that influence a decision to use a direct to patient strategy and why they should be considered.
